Abstract: Disclosed herein are novel copolymers of poly(?-caprolactone) (PCL) and polydopamine (PDA), optionally further comprising a PEG chain, methods for making them as well as their use in pharmaceutical preparations, especially implants or in situ gelling depots, for the treatment of ocular disorders or eye diseases.

Abstract: The invention relates to a hydrophobic thermoplastic copolymer which is in particular of use for manufacturing and/or coating medical devices, in particular implantable medical devices, characterized in that it is obtained by copolymerization, and in that it comprises at least one first monomer unit and at least one second monomer unit onto which is grafted a paramagnetic-ion-chelating ligand which can complex with such a paramagnetic ion or a paramagnetic-ion-chelating ligand which is complexed with such a paramagnetic ion, wherein the second monomer unit is grafted in sufficient amount for the copolymer to be visible in magnetic resonance imaging when it is complexed with said paramagnetic ion. The invention also relates to a method for obtaining said hydrophobic thermoplastic copolymer.

Abstract: The invention relates to a hydrophobic thermoplastic copolymer which is in particular of use for manufacturing and/or coating medical devices, in particular implantable medical devices, characterized in that it is obtained by copolymerization, and in that it comprises at least one first monomer unit and at least one second monomer unit onto which is grafted a paramagnetic-ion-chelating ligand which can complex with such a paramagnetic ion or a paramagnetic-ion-chelating ligand which is complexed with such a paramagnetic ion, wherein the second monomer unit is grafted in sufficient amount for the copolymer to be visible in magnetic resonance imaging when it is complexed with said paramagnetic ion. The invention also relates to a method for obtaining said hydrophobic thermoplastic copolymer.

Abstract: At least one of the monomers is polymerized or copolymerized in bulk, solution, emulsion or suspension, at a temperature which may be as low as 0.degree. C., in the presence of at least one radical-generator compound and at least one metal complex catalyst of formula Ma.sub.a (L).sub.n (M=Cu, Ag or Au; A=Hal, pseudohalogen or carboxylate; L=ligands of M chosen from those of formula ##STR1## R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 =H, C.sub.1 -C.sub.10 alkyl, aromatic or heteroaromatic; Z.sup.1, Z.sup.2 and Z.sup.3 =one of the following: ##STR2## (R.sup.7 to R.sup.18 =H, C.sub.1 -C.sub.10 alkyl, aromatic or heteroaromatic; R.sup.19 and R.sup.20 =H, Hal, C.sub.1 -C.sub.10 alkyl, C.sub.1 -C.sub.10 alkoxy or --(CR.sup.21 R.sup.22)rNR.sup.23 R.sup.24, where R.sup.21, R.sup.22, R.sup.23 and R.sup.24 =H,C.sub.1 -C.sub.10 alkyl, aromatic or heteroaromatic, and r=integer from 1 to 10; it being possible also for not more than two from among Z.sup.1, Z.sup.2 and Z.sup.